[go: up one dir, main page]

CL2013002504A1 - Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion - Google Patents

Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion

Info

Publication number
CL2013002504A1
CL2013002504A1 CL2013002504A CL2013002504A CL2013002504A1 CL 2013002504 A1 CL2013002504 A1 CL 2013002504A1 CL 2013002504 A CL2013002504 A CL 2013002504A CL 2013002504 A CL2013002504 A CL 2013002504A CL 2013002504 A1 CL2013002504 A1 CL 2013002504A1
Authority
CL
Chile
Prior art keywords
preparation
coating
thickness
active ingredient
coated pharmaceutical
Prior art date
Application number
CL2013002504A
Other languages
English (en)
Inventor
Heike Bley
Der Hayden Luc Van
Lauri Lehtonen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CL2013002504A1 publication Critical patent/CL2013002504A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CL2013002504A 2011-03-03 2013-08-30 Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion CL2013002504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11001791 2011-03-03

Publications (1)

Publication Number Publication Date
CL2013002504A1 true CL2013002504A1 (es) 2014-02-14

Family

ID=45808746

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013002504A CL2013002504A1 (es) 2011-03-03 2013-08-30 Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion

Country Status (13)

Country Link
US (1) US20130337056A1 (es)
EP (1) EP2680824A1 (es)
JP (1) JP2014510066A (es)
KR (1) KR20140011358A (es)
CN (1) CN103402503A (es)
AU (1) AU2012222650A1 (es)
BR (1) BR112013022209A2 (es)
CA (1) CA2828754A1 (es)
CL (1) CL2013002504A1 (es)
EA (1) EA201300982A1 (es)
MX (1) MX2013010002A (es)
WO (1) WO2012116814A1 (es)
ZA (1) ZA201307372B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126168B (en) * 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
EP3003286B1 (en) 2013-05-24 2022-04-27 Nanexa AB Method of preparing solid nanoparticles with inorganic coating and use thereof
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
NL2014348B1 (en) * 2015-02-25 2016-10-13 Univ Delft Tech Controlled release from particles encapsulated by molecular layer deposition.
WO2017147318A1 (en) 2016-02-23 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
CN107543798B (zh) * 2016-06-24 2021-02-23 华仁药业股份有限公司 一种载药脂肪乳剂中甲氧基苯胺值的测定方法
CN108938592A (zh) * 2017-05-26 2018-12-07 武汉艾特米克超能新材料科技有限公司 一种低成本的药物包衣方法
CN107281152A (zh) * 2017-06-19 2017-10-24 武汉艾特米克超能新材料科技有限公司 一种基于ald包覆的药物渗透泵制剂及其制备方法
JP7060711B2 (ja) * 2018-01-16 2022-04-26 アプライド マテリアルズ インコーポレイテッド 金属酸化物でカプセル化された薬物組成物及びその調製方法
EP3868366B1 (en) * 2018-10-19 2024-02-28 Towa Pharmaceutical Co., Ltd. Coated solid preparation
JP2022530479A (ja) * 2019-04-26 2022-06-29 アプライド マテリアルズ インコーポレイテッド コーティングされた薬物組成物及びその調製方法
GB2585077A (en) 2019-06-28 2020-12-30 Nanexa Ab Apparatus
JP7801211B2 (ja) * 2019-08-27 2026-01-16 アプライド マテリアルズ インコーポレイテッド 乱用抑止医薬製剤のための気相コーティング技術
KR20220051385A (ko) * 2019-08-27 2022-04-26 어플라이드 머티어리얼스, 인코포레이티드 약제 용해도 조절을 위한 증기상 코팅들
WO2021111098A1 (en) * 2019-12-06 2021-06-10 Nanexa Ab New composition
US20230094101A1 (en) 2020-02-26 2023-03-30 Towa Pharmaceutical Co., Ltd. Coated API Particles
TW202521099A (zh) * 2020-06-05 2025-06-01 美商應用材料股份有限公司 經塗佈的藥物組成物及製備彼之方法
TWI870622B (zh) * 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
CN118215470A (zh) 2021-09-30 2024-06-18 应用材料公司 用于制药应用的低温氧化硅涂层
CN114532448A (zh) * 2022-03-11 2022-05-27 重庆威迪特药业有限责任公司 一种高过胃率粉末包被氧化锌制剂及其制备方法和应用
CN114732793B (zh) * 2022-04-21 2023-06-09 湖北人福药用辅料股份有限公司 一种空心胶囊及其制备方法
EP4518843A1 (en) * 2022-05-03 2025-03-12 Applied Materials, Inc. Drug compositions and methods of preparing the same
KR20240012640A (ko) * 2022-07-20 2024-01-30 (주)엔클로니 경구 투여 제품의 피막 형성용 조성물, 상기 조성물에 의한 피막층을 포함하는 경구 투여 제품 및 레이저 마킹 방법
WO2025096575A1 (en) * 2023-10-30 2025-05-08 Applied Materials, Inc. Methods for preparing drug containing particles enclosed by a laminated aluminum oxide and silicon oxide coating

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ352097A3 (cs) 1995-05-09 1998-04-15 Colorcon Limited Způsob a materiál pro elektrostatické potahování jádra farmaceutických tablet
CN1168789A (zh) * 1996-06-13 1997-12-31 天津达仁堂制药厂 药丸金箔包衣工艺
US6613383B1 (en) * 1999-06-21 2003-09-02 Regents Of The University Of Colorado Atomic layer controlled deposition on particle surfaces
US7972616B2 (en) * 2003-04-17 2011-07-05 Nanosys, Inc. Medical device applications of nanostructured surfaces
CN101237846B (zh) 2005-08-03 2011-09-28 无锡市安惠加医药有限公司 使用粉末材料直接包衣固体制剂
WO2007145657A2 (en) * 2005-11-01 2007-12-21 Massachusetts Institute Of Technology Initiated chemical vapor deposition of vinyl polymers for the encapsulation of particles
US8048448B2 (en) * 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
WO2008066965A2 (en) * 2006-06-23 2008-06-05 The Regents Of The University Of California Articles comprising large-surface-area bio-compatible materials and methods for making and using them
KR100796985B1 (ko) * 2006-06-30 2008-01-22 연세대학교 산학협력단 금박막이 부분 증착된 다기능성 나노입자

Also Published As

Publication number Publication date
JP2014510066A (ja) 2014-04-24
CA2828754A1 (en) 2012-09-07
EP2680824A1 (en) 2014-01-08
ZA201307372B (en) 2014-11-26
CN103402503A (zh) 2013-11-20
KR20140011358A (ko) 2014-01-28
EA201300982A1 (ru) 2014-02-28
MX2013010002A (es) 2013-12-06
AU2012222650A1 (en) 2013-10-17
US20130337056A1 (en) 2013-12-19
WO2012116814A1 (en) 2012-09-07
BR112013022209A2 (pt) 2016-12-06

Similar Documents

Publication Publication Date Title
CL2013002504A1 (es) Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion
EP2657231A4 (en) SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING AND USING SAME
WO2012131463A3 (en) Controlled release pharmaceutical dosage forms
WO2011120904A3 (en) A fast dissolving pharmaceutical composition
EP2799543A4 (en) HUMANIZED ANTI-EPIREGULIN ANTIBODY AND CANCER THERAPY AGENTS WITH THESE ANTIBODY AS ACTIVE AGENT
AR096439A1 (es) Forma de dosificación resistente al uso indebido que contiene una o más partículas
BR112014010206A2 (pt) composto, composição farmacêutica, uso de composto, e, método para a profilaxia ou tratamento de um estado ou condição de doença
BR112014001346A2 (pt) composto nanotransportador, método, composto farmacêutico e uso de um composto
BR112014010179A8 (pt) composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição
WO2014009833A3 (en) Complement pathway modulators and uses thereof
WO2013003669A3 (en) Compositions, methods of use, and methods of treatment
BR112012026570A2 (pt) composto, composição farmacêutica, uso de um composto, método para o tratamento de um indíviduo e produto combinado
CL2015000544A1 (es) Una composicion farmaceutica que comprende regorafenib y al menos un excipiente farmaceuticamente aceptable, en el que la composicion esta recubierta por un recubrimiento que comprende un polimero basado en alcohol polivinilico; y su procedimiento de preparacion.
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
BR112012031981A2 (pt) composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
WO2011120903A3 (en) A fast dissolving pharmaceutical composition
IT1404206B1 (it) Attrezzatura per l'abbacchiatura, particolarmente per l'abbacchiatura di olive e simili
BR112015002824A2 (pt) composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.
BR112013029658A2 (pt) "composição aquosa de revestimento, métodos para formar uma composição aquosa de revestimento, e para prover um revestimento, e, revestimento."
ECSP13012666A (es) Formulacion en comprimidos difusibles y flotantes de un pesticida
BR112013031575A2 (pt) composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.
BR112013024083A8 (pt) agente de redução do desvio de pulverização, composição pesticida, método para reduzir o desvio de pulverização, composição de pulverização, e, método para produzir uma composição de redução do desvio de pulverização
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.